Literature DB >> 21507571

The taccalonolides, novel microtubule stabilizers, and γ-radiation have additive effects on cellular viability.

April L Risinger1, Mohan Natarajan2, Charles R Thomas3, Susan L Mooberry4.   

Abstract

The taccalonolides are novel antimitotic microtubule stabilizers that have a unique mechanism of action independent of a direct interaction with tubulin. Cytotoxicity and clonogenic assays show that taccalonolide A and radiation act in an additive manner to cause cell death. The taxanes and epothilones have utility when combined with radiotherapy and these findings further suggest the additive effects of microtubule targeting agents with radiation on cellular proliferation are independent of direct tubulin binding and are instead a result of the downstream effects of these agents. These studies suggest that diverse antimitotic agents, including the taccalonolides, may have utility in chemoradiotherapy.
Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21507571      PMCID: PMC3104079          DOI: 10.1016/j.canlet.2011.03.022

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  23 in total

1.  Endogenous p53 gene status predicts the response of human squamous cell carcinomas to wild-type p53.

Authors:  L S St John; E R Sauter; M Herlyn; S Litwin; K Adler-Storthz
Journal:  Cancer Gene Ther       Date:  2000-05       Impact factor: 5.987

2.  Effect of docetaxel on the therapeutic ratio of fractionated radiotherapy in vivo.

Authors:  K A Mason; K Kishi; N Hunter; L Buchmiller; T Akimoto; R Komaki; L Milas
Journal:  Clin Cancer Res       Date:  1999-12       Impact factor: 12.531

Review 3.  Taccalonolides: Novel microtubule stabilizers with clinical potential.

Authors:  April L Risinger; Susan L Mooberry
Journal:  Cancer Lett       Date:  2009-10-31       Impact factor: 8.679

4.  The novel taxane analogs, BMS-184476 and BMS-188797, potentiate the effects of radiation therapy in vitro and in vivo against human lung cancer cells.

Authors:  J S Kim; G P Amorino; H Pyo; Q Cao; J O Price; H Choy
Journal:  Int J Radiat Oncol Biol Phys       Date:  2001-10-01       Impact factor: 7.038

Review 5.  Evolution of clinical trials in head and neck cancer.

Authors:  Eddy S Yang; Barbara M Murphy; Christine H Chung; James L Netterville; Brian B Burkey; Jill Gilbert; Wendell G Yarbrough; Robert Sinard; Anthony J Cmelak
Journal:  Crit Rev Oncol Hematol       Date:  2008-11-07       Impact factor: 6.312

6.  Further mechanistic unravelling of the influence of the cell cycle effects on the radiosensitising mechanism of vinflunine, in vitro.

Authors:  Cindy Simoens; Bea Pauwels; Jan B Vermorken; Greet G O Pattyn; Hilde A J Lambrechts; Fabienne Breillout; Filip Lardon
Journal:  Cancer Chemother Pharmacol       Date:  2007-09-27       Impact factor: 3.333

7.  Taccalonolides E and A: Plant-derived steroids with microtubule-stabilizing activity.

Authors:  Tina L Tinley; Deborah A Randall-Hlubek; Rachel M Leal; Evelyn M Jackson; James W Cessac; James C Quada; Thomas K Hemscheidt; Susan L Mooberry
Journal:  Cancer Res       Date:  2003-06-15       Impact factor: 12.701

8.  Comparison of the sulforhodamine B assay and the clonogenic assay for in vitro chemoradiation studies.

Authors:  Bea Pauwels; Annelies E C Korst; Christel M J de Pooter; Greet G O Pattyn; Hilde A J Lambrechts; Marc F D Baay; Filip Lardon; Jan B Vermorken
Journal:  Cancer Chemother Pharmacol       Date:  2003-01-22       Impact factor: 3.333

9.  RhoA is required for cortical retraction and rigidity during mitotic cell rounding.

Authors:  Amy Shaub Maddox; Keith Burridge
Journal:  J Cell Biol       Date:  2003-01-21       Impact factor: 10.539

10.  Comparative study of the radiosensitizing and cell cycle effects of vinflunine and vinorelbine, in vitro.

Authors:  Cindy Simoens; Filip Lardon; Bea Pauwels; Christel M J De Pooter; Hilde A J Lambrechts; Greet G O Pattyn; Fabienne Breillout; Jan B Vermorken
Journal:  BMC Cancer       Date:  2008-02-29       Impact factor: 4.430

View more
  3 in total

Review 1.  Recent progress with microtubule stabilizers: new compounds, binding modes and cellular activities.

Authors:  Cristina C Rohena; Susan L Mooberry
Journal:  Nat Prod Rep       Date:  2014-03       Impact factor: 13.423

Review 2.  Taccalonolides: Structure, semi-synthesis, and biological activity.

Authors:  Yan Li; Yu-Feng Du; Feng Gao; Jin-Bu Xu; Ling-Li Zheng; Gang Liu; Yu Lei
Journal:  Front Pharmacol       Date:  2022-08-11       Impact factor: 5.988

3.  The taccalonolides and paclitaxel cause distinct effects on microtubule dynamics and aster formation.

Authors:  April L Risinger; Stephen M Riffle; Manu Lopus; Mary A Jordan; Leslie Wilson; Susan L Mooberry
Journal:  Mol Cancer       Date:  2014-02-28       Impact factor: 27.401

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.